SGR-1505 is under clinical development by Schrodinger and currently in Phase I for Primary Mediastinal B-Cell Lymphoma.

SGR-1505 is under clinical development by Schrodinger and currently in Phase I for Burkitt Lymphoma. According to GlobalData, Phase I drugs for Burkitt Lymphoma have a 68% phase transition success ...

Symptoms of MCL are similar to those of many other types of non-Hodgkin’s lymphoma and may include one or more of the following: Painless, swollen lymph nodes Fevers and night sweats Unintentional ...

A lymphoma diagnosis often leaves patients with deep uncertainty. In Singapore, this form of blood cancer ranks among the most common cancers, placing fourth among men and fifth among women.

Promising results have been reported recently by the SWOG S1826 trial comparing doxorubicin–vinblastine–dacarbazine (AVD) in combination with nivolumab or with brentuximab vedotin in patients with ...

Through a comprehensive retrospective analysis of a 52-year-old woman with primary ovarian lymphoma (POL) and a review of similar cases over the past decade in the PubMed database, we gained several ...

While B-cell lymphoma always originates in white blood cells called B cells, different B-cell lymphomas vary in aggressiveness, prognosis, and response to treatment. Some B-cell lymphomas can be cured ...

Since the introduction of highly active antiretroviral therapy, the natural history of HIV infection has changed dramatically, and with it the epidemiology of HIV-related lymphoma. HIV-related ...

Description: Cerebral lymphomatosis (CL) is a rare subtype of primary central nervous system lymphoma (PCNSL). In CL, atypical lymphoid cells diffusely infiltrate the cerebral parenchyma without ...

ALK+ large B-cell lymphoma, primary effusion lymphoma, high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements, high-grade B-cell lymphoma - NOS, B-cell lymphoma unclassifiable with ...